[18F]-FMISO PET imaging of tumor hypoxia to predict and monitor response to checkpoint inhibitor therapy.

被引:0
|
作者
Reeves, Kirsten [1 ,2 ]
Song, Patrick
Larimer, Benjamin [4 ]
Sorace, Anna [3 ]
机构
[1] Univ Alabama Birmingham, Dept Radiol, Birmingham, AL USA
[2] Univ Alabama Birmingham, ONeal Comprehens Canc Ctr, Birmingham, AL USA
[3] Univ Alabama Birmingham, Birmingham, AL USA
[4] Univ Alabama Birmingham, Radiol, Birmingham, AL USA
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
407
引用
收藏
页数:2
相关论文
共 50 条
  • [41] [18F]-FMISO PET study of hypoxia in gliomas before surgery: correlation with molecular markers of hypoxia and angiogenesis
    Lien Bekaert
    Samuel Valable
    Emmanuèle Lechapt-Zalcman
    Keven Ponte
    Solène Collet
    Jean-Marc Constans
    Guénaëlle Levallet
    Karim Bordji
    Edwige Petit
    Pierre Branger
    Evelyne Emery
    Alain Manrique
    Louisa Barré
    Myriam Bernaudin
    Jean-Sébastien Guillamo
    European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 1383 - 1392
  • [42] Multi-Parametric Imaging of Glioblastoma using Pseudo-Simultaneous [18F]-FMISO/[18F]-FLT PET
    Nehmeh, Sadek
    Magge, Rajiv
    Schwartz, Theodore
    Fine, Howard
    Liechty, Benjamin
    Kadrmas, Dan
    Schwartz, Jazmin
    Schuck, Phelipi
    Ivanidze, Jana
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [43] 18F-FMISO PET can predict the pathological necrosis of brain tumor
    Toyonaga, Takuya
    Yamaguchi, Shigeru
    Kobayashi, Kentaro
    Manabe, Osamu
    Hirata, Kenji
    Hattori, Naoya
    Shiga, Tohru
    Hatanaka, Kanako
    Yuzawa, Sayaka
    Tamaki, Nagara
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [44] Comparison of three 18F-labeled 2-nitroimidazoles for imaging hypoxia in breast cancer xenografts: [18F]FBNA, [18F]FAZA and [18F]FMISO
    dos Santos, Sofia Nascimento
    Wuest, Melinda
    Jans, Hans-Sonke
    Woodfield, Jenilee
    Nario, Arian Perez
    Krys, Daniel
    Dufour, Jennifer
    Glubrecht, Darryl
    Bergman, Cody
    Bernardes, Emerson Soares
    Wuest, Frank
    NUCLEAR MEDICINE AND BIOLOGY, 2023, 124
  • [45] Functional molecular imaging to predict and monitor response to targeted therapy.
    Gillies, RJ
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9172S - 9172S
  • [46] Imaging hypoxia: Comparing [18F]FMISO autoradiography with pimonidazole immunchistochemistry inhuman xenograft tumors
    Bussink, J.
    Troost, E. G. C.
    Laverman, P.
    Kaanders, J. H. A.
    Philippens, M.
    Lok, J.
    Rennen, H.
    Oyen, W. J. G.
    Boerman, O. C.
    van der Kogell, A. J.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S160 - S161
  • [47] Patient-specific untreated virtual imaging controls for [18F]-FMISO PET imaging of glioblastoma
    Rockne, Russ
    Hawkins-Daarud, Andrea
    Muzi, Mark
    Partridge, Savannah
    Kinahan, Paul
    Swanson, Kristin
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [48] [18F]EF3 is not superior to [18F]FMISO for PET-based hypoxia evaluation as measured in a rat rhabdomyosarcoma tumour model
    Ludwig Dubois
    Willy Landuyt
    Lieselotte Cloetens
    Anne Bol
    Guy Bormans
    Karin Haustermans
    Daniel Labar
    Johan Nuyts
    Vincent Grégoire
    Luc Mortelmans
    European Journal of Nuclear Medicine and Molecular Imaging, 2009, 36 : 209 - 218
  • [49] Analysis of hypoxia in human glioblastoma tumors with dynamic 18F-FMISO PET imaging
    Redha-alla Abdo
    Frédéric Lamare
    Philippe Fernandez
    M’hamed Bentourkia
    Australasian Physical & Engineering Sciences in Medicine, 2019, 42 : 981 - 993
  • [50] Preclinical evaluation of [18F]DiFA, a novel PET probe for tumor hypoxia, in comparison with [18F]MISO
    Yasui, Hironobu
    Zhao, Songji
    Higashikawa, Kei
    Ukon, Naoyuki
    Shimizu, Yoichi
    Matsumoto, Hiroki
    Tamaki, Nagara
    Kuge, Yuji
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58